FDA Inspection 1119195 - BioMarin Pharmaceutical Inc. - February 28, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore BioMarin Pharmaceutical Inc.

Record Details

This FDA Inspection record concerns BioMarin Pharmaceutical Inc., with an inspection on February 28, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: BioMarin Pharmaceutical Inc.
Inspection Date: February 28, 2020
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 7e5e4d0c-38a8-4f92-bc27-edd0f409799a

Violation Codes1

21 CFR 314.80(c)(2)

Full citation text and observation details available on the Dashboard.